LizarBio Therapeutics is a cell therapy company developing curative treatments for incurable diseases using cells. We have a profound knowledge on stem cells, how to cultivate, differentiate, scale and develop them as therapeutic agents to transform the life of patients with severe illnesses. We acknowledge the great potential of this platform to address many conditions. However, we are focusing ou efforts on two diseases: Heart Failure and Rett Syndrome. If you want to know more about how we do this, dont hesitate to contact us. LizarBio Therapeutics: curing incurable diseases using cells
Company Details
- Employees
- 4
- Founded
- -
- Address
- Av. Professor Lineu Prestes, 2242 - Cietec - Sala 229, São Paulo,são Paulo 05508000,brazil
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- pluricellbiotech.com
- Keywords
- Biotechnology, Cardiomyocytes, induced Pluripotent Stem Cells, R&D, rettsyndrome, cell therapy, advanced therapy medicinal proucts, heart failure.
- HQ
- São Paulo, São Paulo
Lizarbio Therapeutics Questions
Lizarbio Therapeutics's website is pluricellbiotech.com
Lizarbio Therapeutics's LinkedIn profile is https://br.linkedin.com/company/lizarbio
Lizarbio Therapeutics has
4 employees.
View email and phone details for 4
employees at Lizarbio Therapeutics.
Lizarbio Therapeutics's industry is
Biotechnology Research
Lizarbio Therapeutics's top competitors are
Br Media Group,
Bravium,
Easy Carros,
Abiquifi,
Repassa,
Mandaê,
Stilingue,
Emerge Brasil,
Staryaai,
Docway.
Lizarbio Therapeutics's categories are Biotechnology Research
Lizarbio Therapeutics's founding year is 2013
